美容护理行业周报：司美格鲁肽注射液临床试验批准，助力体重管理市场发展

Investment Rating - The investment rating for the beauty care industry is "Recommended" [1][3]. Core Insights - The approval of the clinical trial for Semaglutide injection by Huadong Medicine supports the development of the weight management market. Semaglutide is a long-acting GLP-1 receptor agonist that helps lower blood sugar and appetite, and is approved for treating type 2 diabetes and obesity [1][19]. - The medical beauty sector is entering a phase of standardization and maturity, driven by continuous innovation in new materials and technologies, which enhances consumer awareness and expands market capacity [3][23]. Summary by Sections 1. Weekly Market Performance - From October 7 to October 11, 2024, the Shenwan Beauty Care Index fell by 7.96%. The top five gainers included Qingdao Kingking (002094.SZ) and SiHuan Pharmaceutical (0460.HK) [7]. 2. Industry News - The first high-concentration and high-purity "recombinant collagen + hyaluronic acid" liquid dressing was approved on October 8, 2024, by Zhejiang Tianyan Biotechnology Co., Ltd. [11]. - Cynosure launched the new generation PicoSure Pro, enhancing its capabilities for treating pigmentation and acne scars [12]. - The first "silk protein composite gel" was officially approved, indicating ongoing product innovation in the beauty care sector [2]. 3. Key Company Announcements - Huadong Medicine announced the approval of Semaglutide injection for clinical trials, enhancing its competitive position in the GLP-1 market [19]. - Runben Co., Ltd. reported on the listing of restricted shares following its IPO [17]. 4. Weekly Perspective - The approval of Semaglutide injection is expected to significantly impact the weight management market, with Huadong Medicine's comprehensive product pipeline in the GLP-1 space enhancing its competitive edge [19][21]. 5. Investment Recommendations - The report suggests focusing on companies such as Aimeike, Jinbo Biological, Huaxi Biological, Huadong Medicine, and Runben Co., Ltd. as they are expected to benefit from ongoing innovations and market expansion [3][23].